Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus.
Bone Marrow Transplant
; 32 Suppl 1: S49-51, 2003 Aug.
Article
em En
| MEDLINE
| ID: mdl-12931242
At Northwestern University, a phase I/II trial of hematopoietic stem cell transplant (HSCT) for systemic lupus erythematosus (SLE) has shown promising results. A phase III HSCT trial is being developed to confirm efficacy of HSCT vs continuing the currently accepted standard of care, intravenous pulse cyclophosphamide.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ensaios Clínicos Fase III como Assunto
/
Transplante de Células-Tronco Hematopoéticas
/
Lúpus Eritematoso Sistêmico
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
En
Revista:
Bone Marrow Transplant
Ano de publicação:
2003
Tipo de documento:
Article